Lisinopril Tablet Quality Evaluation: A Pharmacopeial Compliance Study
Advances in Clinical Pharmacology and Therapeutics · 2025
DOI: 10.63623/hcfv6209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Clinical Pharmacology and Therapeutics, 2025. Verfasst von Faizah Bakre und 7 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The quality of pharmaceutical products is critical in ensuring therapeutic efficacy and patient safety, particularly in managing chronic conditions like hypertension.
Objectives
This study assessed the quality of five different brands of Lisinopril tablets using pharmacopeial standards to evaluate their compliance with required specifications.
Methods
Five brands were analyzed through High-Performance Liquid Chromatography (HPLC), weight uniformity, hardness, friability, and disintegration tests. HPLC was employed for content assay, while mechanical and release characteristics were assessed using pharmacopoeial protocols.
Results
HPLC analysis showed that all brands contained Lisinopril within the USP acceptable range of 90–110% of the labeled claim. The weight uniformity test confirmed compliance, with all brands falling within the ±7.5% limit. Hardness values varied significantly: brands PR, FI, and ED passed with mean values of 8.5 KgF, 8.3 KgF, and 5.0 KgF respectively, while brands LF and RL failed with values of 3.7 KgF and 3.3 KgF. Friability percentages ranged from 0.105% (FI) to 0.842% (LF), well below the 1% limit. Disintegration times also varied, with all brands meeting the pharmacopeial standard of
Zitieren
APA
Bakre, F., Ayodele, A., Awotuya, I. O., Olufolabo, K., Babasola, F., Daodu, O., Olaitan, J., & Kasim, S. (2025). Lisinopril Tablet Quality Evaluation: A Pharmacopeial Compliance Study. Advances in Clinical Pharmacology and Therapeutics. https://doi.org/10.63623/hcfv6209
Vancouver
Bakre F, Ayodele A, Awotuya IO, Olufolabo K, Babasola F, Daodu O, et al. Lisinopril Tablet Quality Evaluation: A Pharmacopeial Compliance Study. Advances in Clinical Pharmacology and Therapeutics. 2025. doi:10.63623/hcfv6209
BibTeX
@article{Bakre2025,
author = {Bakre, Faizah and Ayodele, Adekunle and Awotuya, Iyanu Oluwafemi and Olufolabo, Katherine and Babasola, Fagbohun and Daodu, Olabanji and Olaitan, James and Kasim, Saka},
title = {Lisinopril Tablet Quality Evaluation: A Pharmacopeial Compliance Study},
journal = {Advances in Clinical Pharmacology and Therapeutics},
year = {2025},
doi = {10.63623/hcfv6209}
}
EUVIMED